Eye Journal
Meeting Abstracts – (Eye 31, S10 (August 2017))
Meeting Abstracts Eye 31, S10 (August 2017). doi:10.1038/eye.2017.148
Lucentis® (ranibizumab) ABBREVIATED UK PRESCRIBING INFORMATION – (Eye 31, S18 (August 2017))
Lucentis® (ranibizumab) ABBREVIATED UK PRESCRIBING INFORMATION Eye 31, S18 (August 2017). doi:10.1038/eye.2017.149
Clinical audit in retina 2016: Chairman’s introduction – (Eye 31, S1 (August 2017))
Clinical audit in retina 2016: Chairman’s introduction Eye 31, S1 (August 2017). doi:10.1038/eye.2017.146 Author: A Tufail
Response to ‘The importance of immunosuppression as risk and prognostic factor for non-melanoma skin cancers’ – (Eye Journal AOP)
Response to ‘The importance of immunosuppression as risk and prognostic factor for non-melanoma skin cancers’ Eye advance online publication, August 25 2017. doi:10.1038/eye.2017.171 Authors: R C Gerring, C T Ott, J M Curry, Z B Sargi & S T Wester
Comment on ‘Licence to save: a UK survey of anti-VEGF use for the eye in 2015′ – (Eye Journal AOP)
Comment on ‘Licence to save: a UK survey of anti-VEGF use for the eye in 2015′ Eye advance online publication, August 25 2017. doi:10.1038/eye.2017.177 Authors: C MacGregor, C Whaley & N Maycock